IDEXX Laboratories, Inc. (IDXX), a pet healthcare innovator, announced Tuesday the promotion of Michael Erickson to President and Chief Executive Officer, effective May 12, 2026. At the same time, President and CEO Jonathan Mazelsky will transition to the role of Executive Chair of the Board of Directors.
Mazelsky has announced his intention to retire from the Company immediately following the Company's annual meeting of shareholders in May 2027, and will work closely with Erickson throughout this extended period to support a seamless transition. Erickson will also join the Board, effective upon his assumption of the role of President and CEO.
Erickson brings nearly two decades of leadership experience and significant healthcare technology and innovation expertise.
Since joining IDEXX in 2011, he has held senior positions across key portions of the Company's business, including diagnostics, software, strategy and corporate accounts, and currently serves as Executive Vice President and General Manager of IDEXX's Global Point of Care Diagnostics and Telemedicine lines of business.
Prior to joining the Company, Erickson advised leading pharmaceutical, biotechnology and health service companies as an Associate Principal at McKinsey & Co.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.